SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
University of California, San Diego
University of California, San Diego
Weill Medical College of Cornell University
University of Rochester
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
University of Utah
H. Lee Moffitt Cancer Center and Research Institute